Jackson Acquisition Co IIJACS
Shareholder meeting
Nov 20, 2026
A meeting is scheduled. The deadline for electing to redeem usually falls two to seven days before it; this proxy did not state it in a form we would parse without guessing, so check the filing.
Cash in trust
$247M
$246,845,170
Trust per share
—
Redemption value
IPO
Dec 2024
—
Combination deadline
Dec 11, 2026
53 days remaining
Filings on record
67
Latest Oct 17, 2026
Overview
Jackson Acquisition Co II is a special purpose acquisition company incorporated and registered with the SEC under CIK 0002039058. It completed its initial public offering in Dec 2024 and listing on NYSE. Class A shares trade under the ticker JACS, units under JACS-UN on NYSE. The vehicle is sponsored by RJ Healthcare through RJ Healthcare SPAC II, LLC. The mandate targets technology, healthcare. IPO closed, trust funded, no definitive agreement announced.
“we intend to focus our search for a target business by concentrating our efforts in identifying high -quality businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry.”
Reading the filings
Arithmetic on what Jackson Acquisition Co II has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Time on the clock
53 days to the Dec 11, 2026 deadline. Inside ninety days a sponsor has three routes and no others: close, call a shareholder vote to extend (which opens a redemption window and usually costs a monthly contribution into the trust), or liquidate and return the cash. This is the window where redemption arithmetic starts to dominate the share price.
Rights, not warrants
Each unit carried one right per unit, convertible into one-tenth (1/10) of a share. A right converts automatically on closing rather than needing to be exercised at a strike, so it is dilution that arrives whatever the share price does — unlike a warrant, which only bites if the stock works. For a holder redeeming at the trust it is worth nothing either way; for one staying in, it is a certain claim rather than an option.
Sponsor record
RJ Healthcare has launched 2 vehicles. Of the 1 that have resolved, 0 closed a combination and 1 liquidated, a 0% completion rate. A sponsor's record is not a forecast, but it does tell you whether the team has taken a deal across the line before.
From listing to the date Jackson Acquisition Co II must close a deal, extend again, or return the trust. The marker is today.
Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.
67 filings in all. 3 in the last three months, against a busiest month of 22.
Scores
Recomputed 2d agoThree readings of Jackson Acquisition Co II, each an unweighted mean of the components shown beneath it, and each component a percentile against every live SPAC rather than an absolute we invented. They describe the setup, not the merit. How they are built
Edge
LowHow much does the structure protect a holder right now?
20/100
- Runway25
56 days
- Sponsor record15
0.0%
Edge reads the setup, not the business. A vehicle can score well on protection and still be a poor place to leave money once a deal closes.
FOMO
LowHow much attention is this vehicle attracting right now?
8/100
- Filing activity17
1 in 30 days
- News coverage0
0 stories in 30 days
Attention is not quality. FOMO rises on news volume and on the market paying above trust, both of which have preceded plenty of disappointments.
Potential
ModerateHow likely is this vehicle to complete a combination, and at what scale?
44/100
- Sponsor record15
0.0%
- Trust scale76
$247M
- Stage40
searching
Potential is about execution, not about the target. It says nothing about whether the eventual deal is worth owning, because the target is usually unknown when the score is computed.
These are derived measures, not ratings of investment merit. They carry no view on the target, no price target and no recommendation, and a high score is not a reason to buy anything.
News on Jackson Acquisition Co II
Last 90 daysNothing in the last 90 days that names this vehicle. We attribute a story only when the release carries the ticker or the registered name, so an empty section means no press release or wire story matched — not that nothing was published. The filings below are the primary record either way.
SEC filing history
Free tier: filings older than 24 hours- PRE 14A
PROXY STATEMENT
Accession 0001213900-26-110243
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001905106-26-000160
- 10-Q
Quarterly report
Accession 0001213900-26-087786
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001905106-26-000091
- 10-Q
Quarterly report
Accession 0001213900-26-056121
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001167557-26-000054
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000886982-26-000196
- 10-K
Annual report
Accession 0001213900-26-032353
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001062993-26-000981
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000927971-26-000016
- 8-K
Notice of delisting or failure to satisfy a listing rule
Items 3.01, 9.01 · Accession 0001213900-26-014277
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001905106-25-000070
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000886982-25-001502
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000312069-25-000579
- 10-Q
Quarterly report
Accession 0001213900-25-107171
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001326389-25-000270
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001076809-25-000091
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001905106-25-000030
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000950170-25-108459
- 10-Q
Quarterly report
Accession 0001213900-25-073677
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001393825-25-000050
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001085146-25-004396
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0000950170-25-072261
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001085146-25-003118
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0000312069-25-000395
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0000769993-25-000285
- 10-Q
Quarterly report
Accession 0001213900-25-041127
- SCHEDULE 13G/A
Amended beneficial ownership report (passive)
Accession 0001085146-25-002810
- SCHEDULE 13G
Beneficial ownership report (passive)
Accession 0001085146-25-002795
- 10-K
Annual report
Accession 0001013762-25-000620
Pro
Track JACS without the delay
Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.
- Filings live, no 24-hour delay
- One click through to the source document
- Deadline calendar out to 12 months
- CSV export, API and MCP access
Cancel any time. Billed monthly in USD.
Jackson Acquisition Co II: questions answered
What is Jackson Acquisition Co II (JACS)?
Jackson Acquisition Co II is a special purpose acquisition company incorporated and registered with the SEC under CIK 0002039058. It completed its initial public offering in Dec 2024 and listing on NYSE. Class A shares trade under the ticker JACS, units under JACS-UN on NYSE. The vehicle is sponsored by RJ Healthcare through RJ Healthcare SPAC II, LLC. The mandate targets technology, healthcare. IPO closed, trust funded, no definitive agreement announced.
How much does Jackson Acquisition Co II hold in trust?
Approximately $246,845,170, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must Jackson Acquisition Co II complete a merger?
By Dec 11, 2026. If no combination closes by then the sponsor must seek a further extension or wind the vehicle up and return the trust.
What happens if Jackson Acquisition Co II does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in Jackson Acquisition Co II, and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
What tickers does Jackson Acquisition Co II trade under?
Class A shares trade as JACS on NYSE, the units as JACS-UN. Units trade first and separate into their component securities roughly 52 days after the IPO; only the Class A shares carry the redemption right against the trust.
Is the trust value the same as the share price for Jackson Acquisition Co II?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
How much dilution do Jackson Acquisition Co II's founder shares and warrants create?
Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.
Who sponsors Jackson Acquisition Co II, and what is their track record?
RJ Healthcare SPAC II, LLC is the sponsor entity, part of the RJ Healthcare franchise. That franchise has launched 2 vehicles in total, of which 0 closed a combination and 1 liquidated, a 0% completion rate on resolved vehicles. Named principals: Richard L. Jackson.
Is Jackson Acquisition Co II tradeable, and where?
Yes. JACS returned a live quote of $10.81 on NYSE. Quotes here are delayed and refreshed on a schedule rather than streamed, so treat the figure as indicative and confirm on your own venue. Units and warrants trade under their own symbols and are quoted separately.
Is Jackson Acquisition Co II a good investment?
That is not a question this site answers. Jackson Acquisition Co II is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this Jackson Acquisition Co II data come from?
Filings Jackson Acquisition Co II submitted to the SEC under CIK 0002039058: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Oct 19, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
RJ Healthcare: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Technology SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All spacs searching for a target
IPO closed, trust funded, no definitive agreement announced.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.